Vascepa is a prescription medication that contains icosapent ethyl, a type of omega-3 fatty acid. It is used to lower triglyceride levels in adults with severe hypertriglyceridemia, which is a condition that increases the risk of heart disease [1]. According to the official Vascepa website, this medication has several benefits. It has been shown to reduce the risk of cardiovascular events, such as heart attack and stroke, in people with high triglyceride levels [2]. In addition, it can also lower non-HDL cholesterol levels, which is another risk factor for heart disease. Vascepa is also well-tolerated and has a low risk of side effects [2].

Recent studies have shown that Vascepa may have even greater cardiovascular benefits for people with diabetes. According to a study published in the American Journal of Managed Care, Vascepa was found to significantly reduce the risk of major adverse cardiovascular events in people with diabetes who had high triglyceride levels [3]. This study adds to the growing body of evidence that Vascepa can help reduce the risk of heart disease in people with certain risk factors.

In summary, Vascepa is a medication that can help lower triglyceride and non-HDL cholesterol levels, which can reduce the risk of heart disease. It is well-tolerated and has a low risk of side effects. Recent studies have also shown that Vascepa may have even greater cardiovascular benefits for people with diabetes who have high triglyceride levels [1][2][3].

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/VASCEPA
[2] https://www.vascepa.com/benefits/
[3] https://www.ajmc.com/view/cardiovascular-benefits-of-vascepa-greater-for-those-with-diabetes-new-reduceit-data-show